Message Font: Serif | Sans-Serif
No. of Recommendations: 0
I have been watching this small bio company for a little over a year now. They had a co-operative agreement with Abbot to develope a Lupus drug. Early results from trials looked unfavorable, and Abbot pulled out. Full results however looked promising, and the company is about to start Phase III trials. The FDA awarded them 'orphan drug status' earlier this week. The price has been creeping up last few weeks, presumably in anticipation of next trials. I know Fools are very interested in biotech and pharma, is anyone else watching LJPC?
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.